How much Stryker spends on buying other companies is its own business, as long as it reserves enough money to compensate victims who are awarded damages after trial.
(PRWEB) January 17, 2013
The Rottenstein Law Group, which represents clients with claims stemming from the failures of defective hip replacement devices manufactured and sold by various companies—including Stryker Corp—is curious about Stryker’s plan to purchase a Hong Kong company in order to expand operations in China.
According to a Reuters report, Stryker Corp will pay $764 million to acquire Trauson Holdings Co Ltd, a Chinese company founded in 1986. Trauson makes spine devices and products for trauma surgeries. The Hong Kong-based company had sales of about $60 million in 2011. China is viewed as one of the fastest-growing markets for orthopedic products.
The acquisition announcement comes soon after an announcement that the company estimates the recall of two of the company’s Rejuvenate and ABG II hip implant devices that began last June “will cost $190 million to $390 million for patient testing and treatment, new surgeries, lawsuits and insurance payments.”
“How much Stryker spends on buying other companies is its own business,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, “as long as it reserves enough money to compensate victims who are awarded damages after trial. And if Stryker is indeed planning to expand in China, we can only hope that it will do so responsibly. Meanwhile, anyone who has been injured by a defective hip device should speak to a lawyer.”
RLG maintains a Stryker Hip Replacement Recall Center to provide comprehensive, up-to-date information about the recalled Stryker Rejuvenate and ABG II modular-neck hip stems. The devices were recalled in early July 2012 because the devices are prone to fretting and corrosion, which can cause the recipient’s tissue around the implant to swell and become painful. The Rottenstein Law Group, a personal injury firm, encourages visitors to link to its sites from their own blogs and web sites to spread information about defective medical products and dangerous drugs.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based law firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)